Perflubron
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
![Printable Version [PDF]](http://data.docslib.org/img/264x/482b35f5dd737293a8d6e7e19b296ebc.webp)
Top View
- Pharmaabkommen A1 E
- Pdf Syndrome: Efficacy and Compatibility with Exogenous Surfactant
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Customs Tariff - Schedule Xxi - 1
- To USP 39–NF 34, First Supplement the Following Index Is For
- Wo 2007/044693 A2
- WO 2012/143143 Al 26 October 2012 (26.10.2012) P O P C T
- (12) Patent Application Publication (10) Pub. No.: US 2012/0329780 A1 Thormann Et Al
- Harmonized Tariff Schedule of the United States (2006) (Rev
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
- 1 Classification and Safety of Microbubble-Based Contrast Agents Emilio Quaia
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- To USP 39–NF 34, Second Supplement the Following Index Is
- (12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
- Pharmaceutical Appendix to the Tariff Schedule 2